Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism;Evaluación diagnóstica y diagnóstico diferencial del hiperparatiroidismo primario

Endocrinologia y Nutricion

Volumn 56, Issue SUPPL. 1, 2009, Pages 14-19

  Quesada Gómez, José Manuel ^a  

^a Red Tematica de Investigacion Coop en Envejecimiento y Fragilidad (RETICEF) Unidad de I+D+i de San   (Spain)

Author keywords

1,25 dihydroxyvitamin D; 25 hydroxyvitamin D; Familial hypercalcemic hypocalciuria; Hypercalcemia; Nephrolithiasis; Osteopenia; Osteoporosis; Primary hyperparathyroidism

Indexed keywords

ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; GRANULOMATOSIS; HYPERCALCEMIA; HYPERVITAMINOSIS; HYPOCALCIURIA; PRIMARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN INTAKE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERPARATHYROIDISM, PRIMARY;

EID: 65549141560     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(09)70851-4     Document Type: Article

References (37)

1. Albright F., and Reifenstein E.C. The parathyroid glands and metabolic bone disease (1948), Williams & Wilkins, Baltimore
2. El-Hajj Fuleihan G. Hyperparathyroidism: Time to Reconsider Current Clinical Decision Paradigms?. J Clin Endocrinol Metab 93 (2008) 3302-3304
3. Heath III H., Hodgson S.F., and Kennedy M.A. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med 302 (1980) 189-193
4. Potts JT Jr, Fradkin JE, Aurbach GD, Bilezikian JP, Raisz LG, eds. Proceedings of the NIH consensus development conference on diagnosis and management of asymptomatic primary hyperparathyroidism. J Bone Miner Res. 1991;6:Suppl 2:2.
5. Silverberg S.J., Shane E., De la Cruz L., Dempster D.W., Feldman F., Seldin D., et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4 (1989) 283-291
6. Guo C.Y., Thomas W.E.G., Al-Dehaimi A.W., Assiri A.M.A., and Eastell R. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 81 (1996) 3487-3491
7. Khosla S., Melton III L.J., Wermers R.A., Crowson C.S., O'Fallon W.M., and Riggs B.L. Primary hyperparathyroidism and the risk of fracture: a population based study. J Bone Min Res 14 (1999) 1700-1707
8. Silverberg S.J., Shane E., Jacobs T.P., Siris E.S., Gartenberg F., Seldin D., et al. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89 (1990) 327-333
9. Mollerup C.L., Vestergaard P., Frøkjær V.G., Mosekilde L., Christiansen P., and Blichert-Toft M. The risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: a controlled historical follow up study. BMJ 325 (2002) 807-810
10. Turken S.A., Cafferty M., Silverberg S.J., De La Cruz L., Cimino C., Lange D.J., et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 87 (1989) 553-557
11. Solomon B.L., Schaaf M., and Smallridge R.C. Psychologic symptoms before and after parathyroid surgery. Am J Med 96 (1994) 101-106
12. Carmeliet G., Van Cromphaut S., Daci E., Maes C., and Bouillon R. Disorders of calcium homeostasis. Best Pract Res Clin Endocrinol Metab 17 (2003) 529-546
13. Walker M.D., and Silverberg S.J. Cardiovascular aspects of primary hyperparathyroidism. J Endocrinol Invest 31 (2008) 925-931
14. Silverberg S.J., and Bilezikian J.P. "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab 88 (2003) 5348-5352
15. Silverberg S.J., Shane E., Jacobs T.P., Siris E., and Bilezikian J.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341 (1999) 1249-1255 [erratum in N Engl J Med. 2000;342:144]
16. Nordenstrom E., Westerdahl J., Lindergard B., Lindblom P., and Bergenfelz A. Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J Surg 26 (2002) 1463-1467
17. Estergaard P., and Mosekilde L. Fractures in patients with primary hyperpara thyroidism: nationwide follow-up study of 1.201 patients. World J Surg 27 (2003) 343-349
18. Clark O.H., Wilkes W., Siperstein A.E., and Duh Q.Y. Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge. J Bone Miner Res 6 Suppl 2 (1991) S135-S142
19. Talpos G.B., Bone III H.G., Kleerekoper M., Phillips E.R., Alam M., Honasoge M., et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128 (2000) 1013-1021
20. Richards M.L., and Thompson N.W. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy?. Surgery 126 (1999) 1160-1166
21. Procopio M., and Borretta G. Derangement of glucose metabolism in hyperparathyroidism. J Endocrinol Invest 26 (2003) 1136-1142
22. Vestergaard P., Mollerup C.L., Frokjaer V.G., Christiansen P., Blichert-Toft M., and Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27 (2003) 216-222
23. Nilsson I.L., Yin L., Lundgren E., Rastad J., and Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe: nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res Suppl 2 (2002) N68-N74
24. Leifsson B.G., and Ahren B. Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81 (1996) 2149-2153
25. Bates D., Clark N.G., Cook R.I., Garber J.R., Hellman R., Jellinger P.S., et al. American College of Endocrinology and American Association of Clinical Endocrinologists position statement on patient safety and medical system errors in diabetes and endocrinology. Endocr Pract 11 (2005) 197-202
26. Silverberg S.J., Gao P., Brown I., LoGerfo P., Cantor T.L., and Bilezikian J.P. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab 88 (2003) 4725-4730
27. Silverberg S.J., and Bilezikian J.P. Primary hyperparathyroidism. In: Rosen C.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. (2008), American Society for Bone and Mineral Research, Washington DC 302-306
28. Binkley N., Krueger D., Gemar D., and Drezner M.K. Correlation among 25-hydroxy vitamin D assays. J Clin Endocrinol Metab 93 (2008) 1804-1808
29. 3 levels in healthy Spanish adults: simultaneous assessment by HPLC. Clin Biochem 41 (2008) 676-680
30. Horwitz M., Hodak S.P., and Steward A.F. Non parathyroid hypercalcemia. In: Rosen C.J. (Ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. (2008), American Society for Bone and Mineral Research, Washington DC 317-322
31. Stewart A.F. Hypercalcemia associated with cancer. N Engl J Med 352 (2005) 373-379
32. Bilezikian J.P., and Silverberg S.J. Asymptomatic primary hyperparathyroidism. N Engl J Med 350 (2004) 1746-1751
33. El-Hajj Fuleihan G., Brown E.M., and Heath III H. Familial benign hypocalciuric hypercalcemia and neonatal primary hyperparathyroidism. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology. 2nd ed. (2002), Academic Press, San Diego, CA, USA 1031-1045
34. Bilezikian J.P., Khan A.A., and Potts Jr. J.T. On behalf of the Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab 94 (2009) 335-339
35. Siegel A., Mancuso M., and Seltzer M. The spectrum of positive scan patterns in parathyroid scintigraphy. Clin Nucl Med 32 (2007) 770-774
36. Gritzmann N., Koischwitz D., and Rettenbacher T. Sonography of the thyroid and parathyroid glands. Radiol Clin North Am 38 (2000) 1131-1145
37. Weber A.L., Randolph G., and Aksoy F.G. The thyroid and parathyroid glands. CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am 38 (2000) 1105-1129